Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fåhraeus Startup & Growth (FSG) is a Swedish venture capital firm based in Lund that specializes in early-stage investments within the life sciences and technology sectors. Founded by serial entrepreneur Christer Fåhraeus and Emanuel Stihl, the firm focuses on innovative companies at the intersection of healthcare and technology, including pharmaceuticals, medtech, and diagnostics. FSG provides hands-on support to its portfolio companies, leveraging the extensive industry experience and networks of its partners to accelerate growth and commercialization. The firm recently closed its second fund (FSG Fund II) at €74 million to expand its reach across the Nordic and European markets. Its portfolio includes notable companies such as Saga Diagnostics, OssDsign, and Yazen.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fåhraeus Startup.